bottom line remain bullish despit stock weak sinc
guidanc call three month ago continu see
room upsid pharma product xarelto darzalex
imbruvica potenti newer asset tremfya erleada feel
upcom earn call present import opportun
compani highlight street see addit growth come
next year off-set expect declin remicad
lower growth outlook medic devic consum segment
particular believ core pharma product perform
well expect compani also get boost recent currenc
move overal forecast higher total compani sale cs
vs consensu ep line
consensu target price remain base
blend dcf valuat rel valuat use
wacc along perpetu growth forecast dcf valuat
appli time ep estim rel valuat
confer call detail report tuesday april
releas expect et confer call et dial-in
believ investor focu call
underli perform jnj main growth driver investor look
stronger top bottom line growth also look understand
willing pursu larger-scal busi develop follow last year
actelion deal see macro debat around drug price
impact strategi go forward result also serv
initi gaug quarterli result rest us larg cap pharma
coverag releas april
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
johnson johnson hold compani engag
 manufactur sale rang product health care
field oper compani organ busi
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
blue sky valuat base greater sale
imbruvica darzalex lai franchis market product
compar current base case assumpt blue sky valuat
base dcf driven wacc termin valu
grey sky valuat base lower sale
imbruvica darzalex lai franchis market product
compar current base case assumpt grey sky valuat
base dcf driven wacc termin valu
 close
figur cs estim metric
us million unless otherwis state
us million unless otherwis state
us million unless otherwis state
us million unless otherwis state
good sold
total expens incom
incom tax basi
ep continu op
dilut ep oper
compani mention price
